DLST | Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) | Citric acid cycle related proteins Enzymes Mitochondrial proteins
| | | | | Expressed in all |
DMPK | Dystrophia myotonica-protein kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
DNTT | DNA nucleotidylexotransferase | Enzymes Plasma proteins
| | | | | Tissue enriched |
DSTYK | Dual serine/threonine and tyrosine protein kinase | Enzymes
| | | | | Mixed |
DTYMK | Deoxythymidylate kinase (thymidylate kinase) | Enzymes
| | | | | Expressed in all |
DYRK1A | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ELOVL5 | ELOVL fatty acid elongase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ELOVL6 | ELOVL fatty acid elongase 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
ELOVL7 | ELOVL fatty acid elongase 7 | Enzymes Predicted membrane proteins
| | | | | Mixed |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERN1 | Endoplasmic reticulum to nucleus signaling 1 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
EXTL2 | Exostosin-like glycosyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FASTK | Fas-activated serine/threonine kinase | Enzymes
| | | | | Expressed in all |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLAD1 | Flavin adenine dinucleotide synthetase 1 | Enzymes
| | | | | Expressed in all |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
FYN | FYN oncogene related to SRC, FGR, YES | Enzymes Plasma proteins
| | | | | Expressed in all |
GALK1 | Galactokinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GALNT1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
GALNT2 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GALNT3 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
GALNT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) | Enzymes
| | | | | Tissue enhanced |
GALNT6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GALT | Galactose-1-phosphate uridylyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
GART | Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
GBE1 | Glucan (1,4-alpha-), branching enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GCNT3 | Glucosaminyl (N-acetyl) transferase 3, mucin type | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GGACT | Gamma-glutamylamine cyclotransferase | Enzymes
| | | | | Tissue enriched |
GGPS1 | Geranylgeranyl diphosphate synthase 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GGT6 | Gamma-glutamyltransferase 6 | Enzymes Predicted membrane proteins
| | | | | Mixed |
GLYATL1 | Glycine-N-acyltransferase-like 1 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GNPNAT1 | Glucosamine-phosphate N-acetyltransferase 1 | Enzymes
| | | | | Expressed in all |
GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial | Cancer-related genes Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GPHN | Gephyrin | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes
| | | | | Expressed in all |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |